{"id":"JGAD000683","research":"hum0311","url":"https://humandbs.dbcls.jp/dataset/JGAD000683","datePublished":"2022-09-27","dateModified":"2024-04-25","values":[{"key":"access-criteria","label":{"ja":"アクセス制限","en":"Access criteria"},"type":"vocabulary","terms":[{"code":"controlled-access-type-1","label":{"ja":"制限公開（Type I）","en":"Controlled-access (Type I)"}}]},{"key":"type-of-data","label":{"ja":"データの種類","en":"Type of data"},"type":"text","text":{"ja":"BBJ第一コホート1,285名の血清サンプルを対象としたNMRによるメタボロームデータ","en":"NMR metabolic biomarkers for 1,285 patients from BBJ 1st cohort"}}],"experiments":[{"label":"メタボローム (NMR)","values":[{"key":"materials-and-participants","label":{"ja":"材料と対象者","en":"Materials and participants"},"type":"text","text":{"ja":"BBJ第一コホート（47疾患）：1,285名 （1,286検体）＋2,570名（2,573検体）＋40,907名（41,411検体） 累計：43,830名 （45,270検体）\nICD10：R00、I44.0-3、I45.5-6、I47-I49、I70.9、L20、J45、I67.1、I63、G45.9、C50、I50、I21.0-9、H25-H26、C53、B18.1、B18.2、C18-C21、J44.9、L51.1-2、L27.0、E10、E11、E88.8、N80、G40、C15、D25、C23、C24、H40、E05.0、K05、R56.0、C81-C86、C90-C93、C22、J30.1、E78.0-5、E78.8-9、J84.1-9、L91.0、K74.6、C34、N04、M80-M81、C56、C25、A15-A19、C61、M05-M06、I20.1、I20.8、I20.9、C16、N20-N23、I20.0、C54","en":"1,285 + 2,570 + 40,907 patients from BBJ 1st cohort (1,286 + 2,573 + 41,411 samples) Total: 43,830 patients (45,270 samples)\nICD10: R00, I44.0-3, I45.5-6, I47-I49, I70.9, L20, J45, I67.1, I63, G45.9, C50, I50, I21.0-9, H25-H26, C53, B18.1, B18.2, C18-C21, J44.9, L51.1-2, L27.0, E10, E11, E88.8, N80, G40, C15, D25, C23, C24, H40, E05.0, K05, R56.0, C81-C86, C90-C93, C22, J30.1, E78.0-5, E78.8-9, J84.1-9, L91.0, K74.6, C34, N04, M80-M81, C56, C25, A15-A19, C61, M05-M06, I20.1, I20.8, I20.9, C16, N20-N23, I20.0, C54"}},{"key":"health-status","label":{"ja":"健康状態","en":"Health status"},"type":"vocabulary","terms":[{"code":"affected","label":{"ja":"罹患","en":"Affected"}}]},{"key":"subject-count","label":{"ja":"対象者数","en":"Subject count"},"type":"number","numbers":[{"value":43830,"unit":null,"high":null}]},{"key":"subject-count-type","label":{"ja":"対象者数の数え方","en":"Counted as"},"type":"vocabulary","terms":[{"code":"individual","label":{"ja":"人数","en":"Individual"}}]},{"key":"cohort","label":{"ja":"コホート","en":"Cohort"},"type":"vocabulary","terms":[{"code":"biobank-japan","label":{"en":"BioBank Japan"}}]},{"key":"sample-description","label":{"ja":"試料説明","en":"Sample description"},"type":"text","text":{"ja":"血清サンプル","en":"serum samples"}},{"key":"tissue","label":{"ja":"組織","en":"Tissue"},"type":"vocabulary","terms":[{"code":"serum","label":{"ja":"血清","en":"Serum"}}]},{"key":"sample-provider","label":{"ja":"試料の入手元","en":"Sample provider"},"type":"text","text":{"ja":null,"en":null}},{"key":"experimental-method","label":{"ja":"実験方法","en":"Experimental method"},"type":"vocabulary","terms":[{"code":"metabolomics","label":{"en":"Metabolomics"}}]},{"key":"targets","label":{"ja":"測定対象","en":"Target"},"type":"text","text":{"ja":"250代謝物 （代謝物リスト）","en":"250 metabolites (List)"}},{"key":"platform","label":{"ja":"プラットフォーム","en":"Platform"},"type":"vocabulary","terms":[{"code":"bruker-avance-iii-hd","label":{"en":"Bruker AVANCE III HD"}}]},{"key":"normalization","label":{"ja":"正規化","en":"Normalization"},"type":"text","text":{"ja":"Nightingale Healthの内製ソフトウェア（quantification library 2020）","en":"Nightingale Health's proprietary software (quantification library 2020)"}},{"key":"analysis-methods","label":{"ja":"解析方法","en":"Analysis method"},"type":"text","text":{"ja":"Nightingale Healthの内製ソフトウェア（quantification library 2020）","en":"Nightingale Health's proprietary software (quantification library 2020)"}},{"key":"policies","label":{"ja":"利用ポリシー","en":"Data use policy"},"type":"vocabulary","terms":[{"code":"nbdc-data-sharing-policy-jgap000001","label":{"ja":"NBDC データ共有ポリシー (JGAP000001)","en":"NBDC data sharing policy (JGAP000001)"}}]}]}],"dataVolume":240452370,"fileFormats":[{"code":"txt","label":{"en":"TXT"}},{"code":"xlsx","label":{"en":"XLSX"}}]}